Home
Venrock Healthcare Capital Partners III reported a 9.9% stake in Surrozen SRZN · 872,546 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 9.9%
- Last report
- First report
- Shares held
- 872,546 sh
- Class
- Common Stock, $0.0001 par value per share
- Stock
- Surrozen SRZN
- Event date
- 25/03/26
- Filed
- 25/04/02
First 5%+ report · 9.9% stake
Surrozen trades, last 26 weeks
What else happened in Surrozen around then
Filed or reported within 30 days of the trade day · 25/02/24~25/04/25Venrock Healthcare Capital Partners III's other 5% stake reports
- Venrock Healthcare Capital Partners III
5% stakeX4 Pharmaceuticals
5% stakeX4 Pharmaceuticals
XFOR
5.6% stake
5,555,047 sh
5.6% stake
Filed 09/21
- Venrock Healthcare Capital Partners III
5% stakeKorsana Biosciences
5% stakeKorsana Biosciences
KRSA
9.9% stake
4,552,277 sh
9.9% stake
Filed 09/15
- Venrock Healthcare Capital Partners III
5% stakeTenax Therapeutics
5% stakeTenax Therapeutics
TENX
4.7% stake
1,574,892 sh
4.7% stake
Filed 08/14
- Venrock Healthcare Capital Partners III
5% stakeOruka Therapeutics
5% stakeOruka Therapeutics
ORKA
7.4% stake
4,556,952 sh
7.4% stake
Filed 08/14
- Venrock Healthcare Capital Partners III
5% stakeJade Biosciences
5% stakeJade Biosciences
JBIO
8.3% stake
5,145,330 sh
8.3% stake
Filed 08/14
